Evidence map›Paper›PMID 41968727›Full record

ArticleImmunoHorizons2026

TGF-β-induced Tregs release extracellular vesicles that modulate CD4+ T-cell proliferation and phenotype in a Nrp1-dependent manner.

María José Moya-Guzmán, Eduardo González-Mienert, Camila Pinto, Karina Pino-Lagos

Abstract read
In one paragraph

Article in ImmunoHorizons, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

María José Moya-GuzmánFacultad de Medicina, Centro de Investigación e Innovación Biomédica, Universidad de los Andes, Santiago, Chile.
Eduardo González-MienertFacultad de Medicina, Centro de Investigación e Innovación Biomédica, Universidad de los Andes, Santiago, Chile.
Camila PintoFacultad de Medicina, Centro de Investigación e Innovación Biomédica, Universidad de los Andes, Santiago, Chile.
Karina Pino-LagosFacultad de Medicina, Centro de Investigación e Innovación Biomédica, Universidad de los Andes, Santiago, Chile.ORCID 0000-0002-4070-6169

Funding

National Agency for Investigation and Development, FONDECYT
6 · The paper itself

Abstract

Neuropilin-1 (Nrp1) is one of the receptors for TGF-β and is associated with the suppressive function of T regulatory cells (Tregs). Based on previous findings on natural Tregs, this work investigated the role of Nrp1 on induced Tregs (iTregs) and their small extracellular vesicles (sEVs) by using a conditional knockout for Nrp1 on FoxP3+ cells. sEVs derived from iTregs were obtained by ultracentrifugation, purified using size exclusion columns, and characterized by nanoparticle tracking analysis. sEVs' impact on CD4+ T-cell cultures was evaluated using functional modulation assays, including CD4+ T-cell phenotypic analysis by flow cytometry and ELISA. We observed a decrease in iTreg induction when CD4+ T cells came from the Nrp1 knockout (KO) mice, indicating that Nrp1 is required for de novo FoxP3 induction/expression. Second, CD4+ T cells cultured with sEV-derived from wild-type (WT) iTregs reduced CD4+ T-cell proliferation, decreased the expression of CD25, and induced FoxP3 and CD73. In contrast, sEVs derived from Nrp1KO iTregs were unable to suppress CD4+ T-cell proliferation and to favor CD25 and CD73 expression. With respect to cytokine production, both sEVs derived from WT and Nrp1KO iTregs inhibited IL-10 and IFN-γ secretion, indicating that Nrp1 is not required for the regulation of these cytokines by sEV. Overall, this study provides new information into the role of Nrp1 in immunomodulation, revealing that Nrp1 signaling plays a role in iTreg differentiation by permitting FoxP3 expression and that iTreg-derived sEVs depend on Nrp1 to control CD4+ T-cell proliferation and phenotype.

Indexed as

CD4-Positive T-LymphocytesExtracellular VesiclesNeuropilin-1T-Lymphocytes, RegulatoryTransforming Growth Factor betaAnimalsCell ProliferationCells, CulturedForkhead Transcription FactorsLymphocyte ActivationMiceMice, Inbred C57BLMice, KnockoutPhenotypeForkhead Transcription FactorsFoxp3 protein, mouseNeuropilin-1Transforming Growth Factor betaExtracellular vesiclesNeuropilin-1T regulatory cells

Identifiers

PMID41968727
PMCPMC13071156

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.